期刊文献+

胆管癌浸润转移过程中PTEN与P53的表达及相互关系的研究 被引量:3

Study of tumor suppress of gene PTEN expression and its correlation with the P53 expression in Cholangio carcinoma
在线阅读 下载PDF
导出
摘要 目的探讨PTEN及P53的表达与胆管癌发生发展的关系,两者表达的相关性及其临床意义。方法应用免疫组织化学SP法对40例胆管癌标本,12例正常胆管组织和30例胆管癌旁组织中PTEN及P53蛋白表达情况进行研究。结果胆管癌中PTEN蛋白的阳性表达率为45.0%(18/40),明显低于正常胆管组织(100.0%,12/12)和癌旁组织90.0%(27/30),其表达与胆管癌的分化程度及有无转移有关而与部位无关。P53蛋白在胆管癌中的阳性表达率为40.0%(16/40),明显高于正常胆管组织0.0%(0/12)和癌旁组织3.3%(1/30)。两者的表达与胆管癌部位无关,但均与胆管癌的病理分级相关,PTEN与P53蛋白在胆管癌中表达具有相关性。结论PTEN蛋白在胆管癌中表达下降,并且其表达与胆管癌的分化程度及有无转移有关而与肿瘤部位无关。P53蛋白在胆管癌中表达升高,其表达与胆管癌的分化程度及有无转移有关而与肿瘤部位无关。胆管癌中PTEN与P53蛋白表达具有相关性。PTEN蛋白在胆管癌中低表达而P53蛋白在胆管癌中高表达,提示PTEN及P53在胆管癌的发生发展中起重要作用,P53突变可能下调PTEN的表达。 [Objective] To investigate the expression of phosphatase and tens in homolog deleted on chromosome 10 (PTEN) and P53 protein in cholangio carcinoma and evaluate the impossible relationship and clinical significance. [Methods] The expressions of PTEN and P53 in 40 cases of cholangio carcinoma, 12 cases of normal biliary duct and 30 cases of para-neoplastic tissue were detected by S-P immunohistochemistry method. [Results] The positive rate of PTEN protein expression was 45.0% (18/40) in cholangio carcinoma, which was significantly lower than that in normalbiliary duct 100.0% (12/12) and that in para-neoplastictissue 90.0%(27/30), and which had no relationship with tumor locus, but was significantly correlated with the degree of differentiation and metastasis. The positive rate of P53 protein expression was 40.0% (16/40) in cholangio carcinoma, which was significantly higher than that in no rmalbiliary duct 0.0% (0/12) and that in para-neoplastictissue 3.3% (1/30), and it had no relationship with tumor locus, but was significantly correlated with the degree of differentiation and metastasis. The PTEN protein expression had correlation with the expression of P53. [ Conclusion] The expression of PTEN protein was significantly lower in cholangiocarcinoma and significantly correlated with the degree of differentiation and metastasis other than the locus of tumor. The expression of P53 protein was associated with the degree of differentiation and metasta- sis, but not with the tumor locus. Moreover, The PTEN protein expression had correlation with the P53 expression.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第11期1720-1723,共4页 China Journal of Modern Medicine
关键词 PTEN基因 P53基因 胆管癌 免疫组织化学 PTEN P53 cholangiocarcinoma inmunohistochemistry
  • 相关文献

参考文献2

二级参考文献21

  • 1JUVAN R,HUDLER P,GAZVODA B,et al.Significance of genetic abnormalities of P53 protein in slovenian patients with gastric carcinoma[J].Croat Med J,2003,48(2):207-217.
  • 2KASTAN MB.Wild-type P53:tumors can't stand it[J].Cell,2005,128(5):837-840.
  • 3MARX J.Oncology.Recruiting the cell's own guardian for cancer therapy[J].Science,2003.315(5816):1211-1213.
  • 4VAN DYKE T.p53 and tumor suppression[J].N Engl J Med,2004,356(1):79-81.
  • 5CHANG YL,WU CT,LIN SC,et al.Clonality and prognostic implications of P53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers[J].Clin Cancer Res,2005,13(1):52-58.
  • 6KOIVUSALO R,MIALON A,PITKANEN H,et al.Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient,but can besustained by inhibiting endogenous nuclear export-dependent P53 antagonists[J].Cancer Res,2002,66(24):11817-11824.
  • 7YOO GH,PIECHOCKI MP,OLIVER J,et al.Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer[J].Laryngoscope,2005,114(11):1871-1879.
  • 8JAIN S,KHURI FR,SHIN DM.Prevention of head and neck cancer:current status and future prospects[J].Curr Probl Concer,2004,28(5):265-286.
  • 9MULLER P,NENUTIL R,VOJTESEK B.Relevance of P53 protein and its mutations for novel strategies in cancer therapy[J].Cas Lek Cesk,2002,143(5):313-317.
  • 10REGULA KM,KIRSHENBAUM LA.Breaking down cell-cycle barriers in the adult heart[J].Circ Res,2004,94(12):1524-1526.

共引文献6

同被引文献96

  • 1乔岐禄,温泉,赵建勋,刘玉村.β-catenin与cyclinD1在胆道肿瘤中的表达及临床意义(英文)[J].中国现代医学杂志,2007,17(2):134-137. 被引量:7
  • 2楼海亚 林开清 叶大风 等.子宫内膜癌组织中PTEN基因的研究.癌症,2005,26(6):63-63.
  • 3Anderson CD,Pinson CW.Berlin J,et al.Diagnosis and treatment of cholangiocarcinoma[J].Oncologist,2004,9(1):43-57.
  • 4Hall PA,Campbell SJ,O'neill M.et al.Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells[J].Carcinogenesis,2000,21(2):153-60.
  • 5Lefkimmiatis K,Caratozzolo MF,Merlo P.D'erchia AM,navarro B, levrero M,sbisa'E,tullo a.p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes[J].Cancer Res,69(22):8563-71.
  • 6Xavier FC,Takiya CM,Reis SR,et al.p63 immunoexpression in lip carcinogenesis[J].J Mol Histol,2009,40(2):131-7.
  • 7Tuna B,Unlu M,Asian G,et al.Diagnostic and prognostic impact of p63 immunoreactivity in renal malignancies[J].Anal Quant Cytol Histol,2009,31(2):118-22.
  • 8Ramalho FS,Ramalho LN,Delia Porta L.et al.Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma[J].J Gastroenterol Hepatol,2006,21(8):1276-80.
  • 9Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [ J ]. Science, 1997, 275 ( 5308 ) : 1943-1947.
  • 10Steck P A, Pershouse M A, Jasser S A, et al. Identifica- tion of a candidate tumour suppressor gene, MMAC1, atchromosome 10q23. 3 that is mutated in muhiple ad- vanced cancers[ J]. Nat Genet, 1997,15 (4) :356-362.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部